Target intelligence / Profile preview

Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S (CTS)

Target
CTS
Molecular classification
Enzyme, Protease, Cysteine protease
01

Overview

Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S are lysosomal cysteine proteases involved in the degradation of intracellular and extracellular proteins. They play essential roles in protein turnover, antigen presentation, apoptosis, and tissue remodeling. Specific members have unique physiological and pathological implications; for example, Cathepsin K is crucial for bone resorption by osteoclasts, Cathepsin S mediates antigen presentation in immune cells, and Cathepsins B and L regulate apoptosis and cancer cell invasion. Therapeutically, they are primary molecular targets for drugs intended to treat cancer, osteoporosis, autoimmune diseases, and fibrosis, but selectivity and safety remain clinical challenges.

Other names
Thiol proteinasecysteine protease BOsteoclast proteinaseMajor excreted protein of kidneyCysteine proteinase SCTS
02

Mechanism of action

Cysteine protease inhibition (block active site, reduce protein breakdown); Modulation of immune cell function and antigen presentation; Reduction of extracellular matrix degradation

03

Biological functions

Intracellular protein degradation and turnoverAntigen processingBone remodelingTissue remodelingApoptosisImmune response and inflammationActivation of the NLRP3 inflammasomeCell cycle regulation
04

Disease associations

CancerOsteoporosis and other bone diseasesInflammatory diseases and autoimmune disordersNeurodegenerative diseases (Alzheimer’s, etc.)Cardiovascular diseaseInfection and immune dysregulation
05

Safety considerations

Off-target effects due to similarity among cathepsin family membersPotential impact on normal tissue turnover and immune functionIncreased risk of infections, impaired bone remodelingDose-dependent toxicity noted in clinical trials
06

Interacting drugs

Odanacatib

2 more in the full profile.

07

Biomarkers

Elevated levels in serum or tissue (for cancer, bone diseases, inflammatory disorders)Expression profiles in tumors, bone, or immune tissues

Beyond the preview

Go deeper on Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S (CTS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin B, Cathepsin K, Cathepsin L, and Cathepsin S (CTS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call